Beta Drugs
add_icon

Beta Drugs

1,450.00
-4.00
(-0.28%)
Market Cap
1,469.85 Cr
PE Ratio
35.53
Volume
0.00
Day High - Low
1,504.20 - 1,380.00
52W High-Low
2,000.00 - 990.10
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
1,469.85 Cr
EPS
40.92
PE Ratio
35.53
PB Ratio
6.02
Book Value
241.46
EBITDA
75.68
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
21.52
Debt to Equity
0.43
Forecast For
Actual

Company News

View All News
Caret
positive
Beta Drugs reported consolidated total revenues of Rs 396.0 crores for FY26, up 7.4% YoY, with EBITDA margins improving to 22.6% from 21.1% in FY25.
positive
Beta Drugs Limited secures GMP inspection approval in Azerbaijan and receives first generic product registrations in Philippines, expanding CIS and Southeast Asian market access.
positive
Beta Drugs announces ₹69.4 crore acquisition of 66.09% stake in IVF specialist Nivian Lifesciences, marking entry into women's health segment. Stock jumps 4% on announcement.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,787.00
#1 4,28,761.16
37.30
#1 58,220.10
6.38
#1 11,565
25.80
44.37
6,565.00
1,74,280.12
67.97
10,560.00
8.73
2,520
13.44
46.75
4,370.00
1,47,900.66
69.16
13,886.20
20.34
2,138
-26.91
50.11
1,373.20
1,10,924.44
28.76
27,711.70
-2.46
3,783
-55.32
52.65
1,076.00
1,08,270.78
21.14
26,719.70
13.65
5,242
7.82
68.91
1,261.90
1,05,323.60
25.35
33,593.30
-0.44
3,998
-86.05
41.47
2,260.00
1,03,291.77
#1 19.30
27,487.50
19.98
5,345
#1 87.72
45.17
2,375.00
98,041.20
50.52
14,277.60
12.03
1,750
31.75
50.42
1,435.00
83,345.03
23.88
33,384.70
3.21
3,376
1.99
48.90
1,394.00
75,256.01
84.57
6,812.90
#1 21.03
884
21.18
76.00
Growth Rate
Revenue Growth
4.35 %
Net Income Growth
-2.17 %
Cash Flow Change
16.84 %
ROE
-7.20 %
ROCE
-36.99 %
EBITDA Margin (Avg.)
-13.02 %

Quarterly Financial Results

Quarterly Financials
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Revenue
89
98
103
106
90
97
Expenses
72
79
81
82
70
76
EBITDA
17
19
23
24
19
21
Operating Profit %
18 %
16 %
20 %
21 %
19 %
19 %
Depreciation
3
4
4
4
4
5
Interest
2
3
3
4
4
4
Profit Before Tax
12
12
16
16
11
12
Tax
3
3
4
4
2
3
Net Profit
9
9
12
12
9
9
EPS in ₹
9.31
9.40
11.59
12.10
8.40
8.93

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
50
83
107
118
158
198
254
436
496
Fixed Assets
13
18
44
40
55
63
65
89
125
Current Assets
32
43
56
68
97
128
178
331
335
Capital Work in Progress
1
15
0
3
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
75
Other Assets
35
50
63
75
103
136
190
347
0
Total Equity & Liabilities
50
83
107
118
158
198
254
436
496
Current Liabilities
14
32
37
33
49
63
85
103
108
Non Current Liabilities
3
9
13
16
17
13
12
136
143
Total Equity
33
41
57
69
92
123
157
197
245
Reserve & Surplus
24
32
48
59
83
113
148
187
235
Share Capital
9
9
10
10
10
10
10
10
10

Cash Flow

Cash Flow
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
12
-9
2
5
7
2
10
118
Investing Activities
-11
-21
-15
-6
-22
-19
-14
-36
Operating Activities
17
0
8
19
30
23
31
36
Financing Activities
5
12
9
-8
-1
-3
-8
118

Share Holding

% Holding
Aug 2017
Sept 2017
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Nov 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Nov 2025
Dec 2025
Mar 2026
Promoter
93.78 %
93.78 %
66.68 %
66.68 %
66.68 %
66.71 %
66.71 %
66.71 %
66.71 %
66.71 %
66.73 %
66.73 %
66.73 %
66.73 %
66.73 %
66.73 %
66.73 %
66.73 %
66.73 %
66.73 %
66.73 %
66.73 %
66.73 %
64.90 %
66.73 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.32 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
1.14 %
0.90 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.02 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
1.89 %
0.29 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
21.63 %
21.88 %
22.72 %
22.86 %
22.86 %
22.59 %
22.61 %
22.60 %
22.52 %
22.24 %
22.37 %
22.33 %
22.35 %
21.96 %
21.70 %
21.63 %
21.60 %
21.81 %
21.75 %
21.81 %
21.78 %
21.78 %
21.81 %
Others
6.22 %
6.22 %
11.68 %
11.44 %
10.60 %
10.43 %
10.43 %
10.70 %
10.68 %
10.69 %
10.75 %
11.03 %
10.90 %
10.60 %
10.91 %
11.31 %
11.56 %
11.64 %
11.66 %
11.45 %
11.51 %
11.45 %
11.49 %
10.29 %
10.26 %
No of Share Holders
0
0
0
540
507
542
675
762
1,296
1,407
1,424
1,451
1,722
1,928
2,116
2,323
2,567
2,793
2,882
3,045
3,139
3,184
3,003
3,694
3,184

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 1,693.10 1,676.00
06 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Nov 2024 1,971.30 1,944.15
12 Nov 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
12 Nov 2024 1,892.10 2,178.40
21 Dec 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
21 Dec 2024 2,192.00 2,060.05
26 Mar 2025 BONUS Bonus
1:20
26 Mar 2025 1,850.00 1,935.00
15 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
15 May 2025 1,750.35 1,854.00
06 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Nov 2025 1,855.00 1,743.15
04 Feb 2026 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
04 Feb 2026 1,585.00 1,439.40
14 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Feb 2026 1,412.40 1,373.60
14 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 May 2026 1,322.30 1,416.80

Announcements

General Updates10 days ago
Outcome of Board Meeting10 days ago
Analysts/Institutional Investor Meet/Con. Call UpdatesMay 22, 2026
Copy of Newspaper PublicationMay 16, 2026
Analysts/Institutional Investor Meet/Con. Call UpdatesMay 15, 2026
Analysts/Institutional Investor Meet/Con. Call UpdatesMay 15, 2026
Outcome of Board MeetingMay 14, 2026
Monitoring Agency ReportMay 14, 2026
Statement of deviation(s) or variation(s) under Reg. 32May 14, 2026
Analysts/Institutional Investor Meet/Con. Call UpdatesMay 12, 2026
Outcome of Board MeetingApr 25, 2026
General UpdatesApr 22, 2026
Price movementApr 07, 2026
Disclosure under SEBI Takeover RegulationsApr 07, 2026
Certificate under SEBI (Depositories and Participants) Regulations, 2018Apr 06, 2026
Price movementApr 06, 2026
General UpdatesApr 03, 2026
Trading WindowMar 31, 2026
General UpdatesMar 20, 2026
General UpdatesMar 16, 2026
Copy of Newspaper PublicationFeb 16, 2026
Monitoring Agency ReportFeb 14, 2026
Outcome of Board MeetingFeb 14, 2026
Statement of deviation(s) or variation(s) under Reg. 32Feb 14, 2026
General UpdatesFeb 12, 2026
Shareholders meetingFeb 04, 2026
Shareholders meetingFeb 04, 2026
CorrigendumJan 30, 2026
Copy of Newspaper PublicationJan 13, 2026
Shareholders meetingJan 12, 2026
General UpdatesJan 11, 2026
General UpdatesJan 10, 2026
Outcome of Board MeetingJan 09, 2026
Certificate under SEBI (Depositories and Participants) Regulations, 2018Jan 07, 2026
UpdatesJan 06, 2026
Trading WindowJan 06, 2026
Trading WindowDec 31, 2025
Analysts/Institutional Investor Meet/Con. Call UpdatesDec 12, 2025
General UpdatesDec 08, 2025
Analysts/Institutional Investor Meet/Con. Call UpdatesDec 02, 2025
Outcome of Board MeetingNov 29, 2025

Technical Indicators

RSI(14)
Neutral
62.16
ATR(14)
Volatile
83.03
STOCH(9,6)
Overbought
86.51
STOCH RSI(14)
Overbought
90.11
MACD(12,26)
Bullish
14.13
ADX(14)
Weak Trend
20.24
UO(9)
Bearish
48.26
ROC(12)
Uptrend And Accelerating
14.32
WillR(14)
Overbought
-15.07